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INTRODUCTION
The intake of diets low in fat and high in com-
plex carbohydrates from grains, fruits, and vegeta-
bles is associated with a lower risk of chronic dis-
eases (1). Although this has been suggested to be
due to the adverse effect of fat and the potential
health benefits of dietary fiber, other constituents
associated with high - fiber foods may also be re-
sponsible in part for the health benefit of such diets.
In recent years, phytoestrogens have been attract-
ing increasing attention among the public and in
the medical community because of evidence from a
large body of literature suggesting that consump-
tion of plant - based foods rich in these phytochemi-
cals may benefit human health (1 - 8). Substantial
data from epidemiologic surveys and nutritional in-
tervention studies in humans and animals suggest
that dietary phytoestrogens have protective effects
against menopausal symptoms and a variety of dis-
orders, including cardiovascular disease, cancer,
hyperlipidemia, osteoporosis, and various forms of
chronic renal disease (1 - 8). In this review, evidence
for a possible role of dietary phytoestrogens in im-
munity is examined and various mechanisms by
which this class of phytoestrogens may affect im-
munity are discussed.
ISOFLAVONES
The majority of phytoestrogens found in typical
human diets can be categorized into two primary
classes : isoflavones and lignans. Phytoestrogens
in the diet may have a role in modulating hormone-
related disease based in their structural similarity
to the estrogen 17β - estradiol (Fig. 1). Isoflavones
make up the most common form of phytoestrogens.
They have a common diphenolic structure that re-
sembles the structure of the potent synthetic es-
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trogens diethylstilbestrol and hexestrol. Two of the
major isoflavones found in humans are genistein
and daidzein. Genistein and daidzein are parent
compounds, which are metabolized from their plant
precursors, biochanin A and formononetin, respec-
tively. In plants, isoflavones are inactive when pre-
sent in the bound form as glycosides, but when the
sugar residue is removed, these compounds become
activated. These plant compounds undergo fermen-
tation by intestinal microflora, with both metabolites
and unfermented parent (aglycone) compounds be-
ing liable to absorption. In the body, they do not un-
dergo any further metabolism and are excreted in
the urine (9). In the colonic microflora, daidzeinmay
be metabolized to equol or O - demethylangolesin
and genistein may be metabolized to p -ethyl phe-
nol. Daidzein, genistein, equol, and O - demethy-
langolesin are the major phytoestrogens detected
in the blood and urine of humans and animals.
FOOD SOURCES OF PHYTOESTROGENS
Phytoestrogens are found in various plants con-
sumed by humans, including legumes, seeds, and
whole grains. The most abundant food sources of
isoflavones are soybean and its products (Table 1).
Other beans, lentil, peas, and clover contain very
small quantities of isoflavones. The amount of isofla-
vone in soybean varies according to the type of soy-
bean, geographic area of cultivation, and harvest
year. In addition, the isoflavone content of differ-
ent soy products varies substantially as a result of
differences in processing methods (10). In soybean,
isoflavones are closely associated with protein. The
protein content of soybeans is more than 36% by
weight. Processed soybean proteins and foods pro-
vide various amounts of genistein and daidzein, as
either conjugated glycones or as aglycone forms.
Mature and roasted soybeans and commercially
available soy products (soy flour and textured pro-
tein) contain 0.1 -5 mg isoflavones/g protein. Green
soybeans and tempeh are intermediate sources of
isoflavones, providing 0.3 mg/g soy protein. One
serving of traditional soy foods provides 0.25 - 40
mg isoflavones (11). Tofu, isolated soy protein, and
some soymilk preparations provide 0.1 - 2 mg isofla-
vones/g soy protein. Alcohol extraction dissociates
isoflavones bound to soy protein ; therefore, alcohol-
denatured soy protein is devoid of a significant
amount of isoflavones (12).
SOY ISOFLAVONE AND IMMUNITY
Genistein is one of the most extensively studied
isoflavones for its effect on immunity. In some
studies on the effect of genistein on immunity, ova-
riectomized (OVX) mice were used to avoid the ef-
fect of endogenous estrogen. Although this model
is useful for investigating the direct effect of ge-
nistein on immune function, it does not always re-
flect physiological conditions in vivo . Indeed, some
findings in OVX and non-OVX models are differ-
ent, and care should be taken in interpreting those
results (Table 2).
Fig. 1 Structure of soy isoflavones
Table 1. Isoflavone contents of soy products1.
Total
Soy products isoflavones Genistein Daidzein
Roasted soybeans 26612 1426 941
Soy -protein isolate 987 640 191
Tempeh 865 422 405
Tofu 532 245 238
Soy drink 28 21 7
1 Adapted from Wang et al. (11).
2 μg/g
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1) Lymphocyte proliferation response in vitro
A relatively high concentration of genistein in-
hibits lymphocyte proliferation response induced
by mitogen or alloantigen in vitro (13). The tyro-
sine kinase signaling cascade plays a pivotal role in
the activation of various inflammatory cells. Ge-
nistein is known to be an inhibitor of protein tyro-
sine kinase, and its activity may contribute to the
suppressive effect in vitro .
2) Thymocyte differentiation
The thymus is a central organ for T cell differen-
tiation. Genistein induces dose - responsive reduc-
tions in thymic weight and size in OVX mice (14).
Genistein decreases thymocyte numbers by up to
86% and doubles apoptosis. Increased apoptosis
is involved in the mechanism by which genistein
causes loss of thymocyte. Administration of ge-
nistein to mice caused decreases in percentages of
thymic CD4+CD8- and double - positive CD4+CD8+
thymocytes, providing evidence that genistein may
affect early thymocyte maturation and maturation
of CD4+CD8- helper T cells. Treatment of genistein-
administered mice with anti -estrogen ICI 182,780
partially restored thymic weight. Therefore, the ef-
fect of genistein on thymic weight is mediated in
part by the estrogen receptor.
3) Cellular and humoral immune responses
Genistein reduces the numbers of peripheral
CD4+ and CD8+ T cells, and this reduction might
come from thymic atrophy (14). Delayed - type hy-
persensitivity (DTH) reaction is classified as type
IV allergy response and is mainly mediated by T
cells and macrophages. Genistein suppresses DTH
reaction to oxazolone and granulocyte -mediated re-
sponse (15). In addition to cellular immune re-
sponse, genistein also suppresses antigen (Ag) -
induced antibody (Ab) production. In ovalbumin
(OVA)-immunized mice, genistein suppresses OVA-
specific IgG levels. Interestingly, an inhibitory ef-
fect of genistein on Ab production was not observed
when thymus - independent Ag TNP -Ficoll was used
(16), suggesting that the suppressive effect of ge-
nistein on Ag-specific Ab response is not a result
of a direct inhibitory effect on B cells. In addition,
genistein did not affect the expression of MHC class
II, CD80 and CD86 and the Ag-presenting capacity
of CD11c+ dendritic cells (16). Although genistein
inhibits OVA-specific T cell proliferation and cy-
tokine responses, production of IFN- γ and IL -4
Table 2. Effects of soy isoflavones on immune functions in vivo
Species Compound Dose (day) OVX Effects Reference
Mouse Genistein 8 - 200 mg/kg + thymus weight thymocyte apoptosis 14
number of peripheral lymphocytes
Ag - specific Ab titer
Mouse Genistein 8 - 80 mg/kg + DTH response 21
1000 - 1500 ppm number of LN CD4+ and CD8+ T cells
Mouse Genistein 4 - 20 mg/kg + Ag - specific T cell response 16
Ag - specific Ab titier
Ag - specific cytokine production
 Dendritic cell function
 CD4+CD25+ T cell function
Mouse Genistein 30 mg/kg - anti - collagen II Ab 15
DTH response
Mouse Genistein 4 - 20 mg/kg - IFN - γ and IL - 4 production 17
thymus weight
Mouse Genistein 2 - 20 mg/kg - cytotoxic T cell and NK cell activity 19
resistance to B16F10 tumor
Mouse Genistein 4 - 20 mg/kg - inflammatory dermatitis in NC mice 23
IFN - γ production ;IL - 4 production
Guinea pig Genistein 15 mg/kg - Ag - induced asthma 24
Mouse Daidzein 10 - 40 mg/kg - Thymus weight ;phagocytic activity 31
Ag - specific IgM Ab
The Journal of Medical Investigation Vol. 55 August 2008 169
from T cells of genistein - treated mice is increased
upon stimulation with anti -CD3 mAb (16, 17).
4) Tumor immunity
It has been reported that genistein increased
host resistance to B16F10 tumor and induced a
dose -dependent increase in cytotoxic T cell and NK
cell activities (18, 19). However, genistein did not
inhibit growth of tumor cells in athymic nude mice
(20). These conflicting findings in euthymic and
athymic mice suggest that genistein inhibits growth
of a tumor not by direct inhibition but by enhanc-
ing immune cell function. The finding that tumor
cells cultured with serum from genistein - treated
mice did not suppress their growth ability supports
the speculation that genistein enhances anti - tumor
immunity (18).
5) Diseases (Animal model)
The effect of genistein on collagen - induced ar-
thritis (CIA) has been investigated. Mice treated
with genistein prior to immunization with collagen
type II (CII) showed less frequent and less severe
arthritis than did controls (21). Histopathological
examination of the joints showed that synovial hy-
perplasia and bone/cartilage destruction was less
frequent in joints of genistein - treated mice. An
interesting finding is that levels of anti -CII -Abs in
serum were significantly lower in groups of mice
treated with genistein. Notably, there are signifi-
cant correlations between CII -Ab levels and bone/
cartilage destruction.
NC/Nga mice have been shown to develop spon-
taneous severe dermatitis when kept in conventional
conditions (22). Oral administration of genistein
suppresses the development of dermatitis but does
not suppress serum IgE levels in NC/Nga mice.
The mechanism underlying the suppressive effect
of genistein on the development of dermatitis is not
known, but little contribution of Th1/Th2 balance
has been reported (23).
Allergic asthma is a chronic airway inflammatory
disease that manifests itself as recurrent revers-
ible acute bronchoconstriction and airway hyperre-
sponsiveness (AHR). Duan, et al. examined anti -
inflammatory effects of genistein on a guinea pig
model of asthma (24). Genistein markedly inhib-
ited OVA- induced and methacholin - induced acute
bronchoconstriction. In addition, genistein reduced
OVA- induced increases in total cell counts and
eosinophils recovered in bronchoalveolar lavage
fluid, and attenuated OVA- induced airway hyperre-
sponsiveness to inhaled methacholine. The authors
speculated that the inhibitory effect of genistein on
AHR is attributed to the block of protein tyrosine
kinase signaling cascades.
MECHANISMS OF THE EFFECTS OF GE-
NISTEIN ON IMMUNE FUNCTIONS
Estrogen receptor -dependent and - independent
mechanisms have been proposed for the immune
modulating effect of genistein since genistein is
structurally similar to estrogen. Indeed, expression
of the estrogen receptor in thymocytes, lympho-
cytes and macrophages has been reported (25, 26).
Estrogen is known to suppress the activity of im-
mune cells and to suppress the development of DTH
reaction (27), CII - induced arthritis (28) and ex-
perimental autoimmune encephalomyelitis (29) in
animal models. It is possible that genistein has
estrogen - like action and modulates immune func-
tion mediated by the estrogen receptor. However,
several studies have shown that blockade of the
estrogen receptor pathway partially abolishes the
action of genistein. Genistein is known to be a
broad - spectrum protein tyrosine kinase inhibitor
(30), and its activity may contribute to one of the
estrogen receptor - independent mechanisms. In vitro
experiments have shown that genistein at a dose
of more than 10 μM inhibits both tyrosine phos-
phorylation and binding of the nuclear factor to the
specific promoter region, resulting in inhibition of
proliferation response and cytokine production.
DAIDZEIN AND ITS METABOLITES
Data on the effects of formononetin, its metabo-
lites daidzein and equol are limited. An in vivo study
has shown that administration of daidzein increases
the phagocytic response of peritoneal macrophages
and the thymus weight in a dose -dependent man-
ner (31), and it has been shown that daidzein in-
creases proliferation response of splenocytes to both
Con A and LPS stimulations in vitro (32). For-
mononetin and its metabolites have been found up-
regulate interleukin - 4 production in activated T
cells via increased AP -1 DNA binding activity (33).
This finding suggests that phytoestrogen and some
of their metabolites may affect allergic responses
via the enhancement of IL - 4 production in T cells.
T. Sakai, et al. Genistein and immunity170
PERSPECTIVE
Soy foods are traditionally consumed in relatively
large amounts in Asian countries, such as China and
Japan (34, 35), and in small amounts in Western
countries, such as North American and European
countries (36, 37). This may account for the low-
ered risk of hormone - related cancer and osteopo-
rosis in Asian populations compared to that in West-
ern populations (1 - 8). Recent evidence suggests
that isoflavones in soy modulate immune function
positively or negatively. The characteristic feature
of genistein is its anti - inflammatory effect, and this
effect has been demonstrated in animal models.
However, epidemiologic study on the association of
dietary soy or isoflavone consumption with allergic
disorders is limited. Miyake, et al. conducted a
cross - sectional study on the relationship between
dietary soy products and isoflavone intake and the
prevalence of allergic rhinitis (38). Compared with
dietary intake of total soy product, soy protein,
daidzein and genistein in the first quartile, consump-
tion of these substances in the fourth quartile was
found to be independently associated with reduced
prevalence of allergic rhinitis, although no signifi-
cant dose-response relationships were observed.
This finding indicates the possibility that a high in-
take of soy and isoflavones is associated with re-
duced prevalence of allergic rhinitis. However, fur-
ther investigations are needed to determine whether
soy and soy isoflavone consumption has a preven-
tive effect against allergic diseases.
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